Canaan (NASDAQ:CAN) reported its Q2 earnings results on Thursday, August 18, 2022 at 04:45 AM.
Here's what investors need to know about the announcement.
Companies Reporting Before The Bell
• Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.
Understanding Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Key Takeaways:
Ebang, a maker of cryptocurrency mining machines, has been warned about potential delisting from the Nasdaq after its stock remained below $1 for a prolonged period
Rival crypto mining equipment maker Canaan repurchased warrants it issued last year after its stock plunged to levels well below the exercise price
Canaan Inc. Announces The Repurchase of Over 4.72 Million Outstanding Warrants for Approximately US$6.61 Million
BEIJING, June 23, 2022 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the
Gainers
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%.